Use of IL-I antibodies for treating ophthalmic disorders

Details for Australian Patent Application No. 2007238677 (hide)

Owner Novartis AG

Inventors Neuner-Jehle, Martin; Markabi, Olivier Sabri; Keating, Mark Taylor; Yoo, Dana Sue; Scassellati-Sforzolini, Baldo

Agent Davies Collison Cave

Pub. Number AU-B-2007238677

PCT Pub. Number WO2007/120828

Priority 60/747,134 12.05.06 US; 60/792,293 14.04.06 US

Filing date 12 April 2007

Wipo publication date 25 October 2007

Acceptance publication date 10 March 2011

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/120828 Priority application(s): WO2007/120828

10 March 2011 Application Accepted

  Published as AU-B-2007238677

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238685-Transdermal methods and systems for the delivery of anti-migraine compounds

2007238676-Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders